• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期癌症患者及其对补充和替代医学的使用。

Patients with advanced cancer and their usage of complementary and alternative medicine.

机构信息

J.W. Goethe University, Frankfurt, Germany.

出版信息

J Cancer Res Clin Oncol. 2013 Sep;139(9):1515-22. doi: 10.1007/s00432-013-1460-y. Epub 2013 Jul 6.

DOI:10.1007/s00432-013-1460-y
PMID:23832609
Abstract

PURPOSE

A total of 40 % of cancer patients use complementary and alternative medicine (CAM), and patients with advanced cancer use CAM more often than others. The aim of our study was to gather data on CAM use and reasons to use CAM of patients with advanced cancer being admitted for residential palliative care and their relatives.

METHODS

Structured interviews were carried out with 25 patients and 25 relatives of those patients, respectively, of a German comprehensive cancer center based on a standardized questionnaire of the working group Prevention and Integrative Oncology of the German Cancer Society.

RESULTS

Median age of patients was 64.5 years (relatives: 53.5); 15 patients were male and 10 were female (relatives: 7 and 18). In total, 40 % of all patients used some CAM method at the time of the study, supplements and prayer being the most frequent method. Main reasons for using CAM were to sustain one's own strength (52 % for patients and 72 % for relatives) and to be able to do something by oneself (36 and 40 %). Sources of information were television/radio (48 and 28 %) and family/friends (40 and 48 %). Relatives also use the Internet (40 %).

CONCLUSIONS

Also for patients in palliative care and their relatives, CAM is important. Reasons for using CAM are similar for patients with less advanced cancer. As most patients do not discuss using CAM with their physician, side effects and interactions of biologically based treatments may be dangerous. The desire of patients to act autonomously should be encouraged. Yet, physicians should ensure safe administration of complementary methods by including CAM in their communication with the patient and the family.

摘要

目的

共有 40%的癌症患者使用补充和替代医学(CAM),晚期癌症患者比其他患者更常使用 CAM。我们的研究目的是收集接受住院姑息治疗的晚期癌症患者及其家属使用 CAM 的情况和使用原因的数据。

方法

基于德国癌症协会预防和综合肿瘤学工作组的标准化问卷,对德国一家综合癌症中心的 25 名患者和 25 名患者亲属分别进行了结构访谈。

结果

患者的中位年龄为 64.5 岁(亲属:53.5 岁);15 名患者为男性,10 名患者为女性(亲属:7 名男性和 18 名女性)。在研究时,所有患者中有 40%使用了某种 CAM 方法,补充剂和祈祷是最常见的方法。使用 CAM 的主要原因是保持自身力量(患者为 52%,亲属为 72%)和能够自己做些事情(患者为 36%,亲属为 40%)。信息来源为电视/广播(患者和亲属均为 48%)和家庭/朋友(患者和亲属均为 40%)。亲属还使用互联网(40%)。

结论

即使是在姑息治疗中的患者及其亲属,CAM 也很重要。使用 CAM 的原因与癌症程度较轻的患者相似。由于大多数患者没有与医生讨论使用 CAM,因此基于生物的治疗方法的副作用和相互作用可能会很危险。应鼓励患者自主行动的愿望。然而,医生应通过将 CAM 纳入与患者和家属的沟通中,确保补充方法的安全管理。

相似文献

1
Patients with advanced cancer and their usage of complementary and alternative medicine.晚期癌症患者及其对补充和替代医学的使用。
J Cancer Res Clin Oncol. 2013 Sep;139(9):1515-22. doi: 10.1007/s00432-013-1460-y. Epub 2013 Jul 6.
2
Sexual Harassment and Prevention Training性骚扰与预防培训
3
Attitudes of members of the German Society for Palliative Medicine toward complementary and alternative medicine for cancer patients.德国姑息医学协会成员对癌症患者补充和替代医学的态度。
J Cancer Res Clin Oncol. 2014 Jul;140(7):1229-37. doi: 10.1007/s00432-014-1656-9. Epub 2014 Apr 6.
4
The use of complementary and alternative medicine by patients in routine care and the risk of interactions.患者在常规护理中使用补充和替代医学及其相互作用的风险。
J Cancer Res Clin Oncol. 2018 Mar;144(3):551-557. doi: 10.1007/s00432-018-2587-7. Epub 2018 Jan 22.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
6
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.利用预后信息为乳腺癌患者选择辅助性全身治疗的成本效益
Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340.
7
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
8
Falls prevention interventions for community-dwelling older adults: systematic review and meta-analysis of benefits, harms, and patient values and preferences.社区居住的老年人跌倒预防干预措施:系统评价和荟萃分析的益处、危害以及患者的价值观和偏好。
Syst Rev. 2024 Nov 26;13(1):289. doi: 10.1186/s13643-024-02681-3.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

引用本文的文献

1
Integrative Oncology and Palliative Care in Iran: Mind, Body, Religion, and Spirituality.伊朗的综合肿瘤学与姑息治疗:身心、宗教与灵性
Curr Psychiatry Rep. 2025 Sep 11. doi: 10.1007/s11920-025-01640-6.
2
Response rates, survival status and adverse events of placebo in randomized control trials for hepatocellular carcinoma: A meta-analysis.肝细胞癌随机对照试验中安慰剂的缓解率、生存状况及不良事件:一项荟萃分析。
World J Hepatol. 2025 Aug 27;17(8):108533. doi: 10.4254/wjh.v17.i8.108533.
3
Quality Assessment of YouTube Videos on Complementary and Alternative Medicine (CAM) for Cancer Using a Newly Developed Tool.

本文引用的文献

1
Potential interactions of complementary and alternative medicine with cancer therapy in outpatients with gynecological cancer in a comprehensive cancer center.综合癌症中心妇科癌症门诊患者中,补充和替代医学与癌症治疗的潜在相互作用。
J Cancer Res Clin Oncol. 2013 Mar;139(3):357-65. doi: 10.1007/s00432-012-1336-6. Epub 2012 Oct 26.
2
Prevalence and predictors of complementary and alternative medicine (CAM) use by men in Australian cancer outpatient services.澳大利亚癌症门诊服务中男性使用补充和替代医学(CAM)的流行率及预测因素。
Ann Oncol. 2012 Jun;23(6):1571-8. doi: 10.1093/annonc/mdr521. Epub 2011 Nov 5.
3
How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis.
使用新开发工具评估关于癌症的补充和替代医学(CAM)的 YouTube 视频的质量。
Integr Cancer Ther. 2024 Jan-Dec;23:15347354241293417. doi: 10.1177/15347354241293417.
4
Exploring Integrative Approaches: Insights Into Complementary Medicine Practices Among Breast Cancer Survivors in Saudi Arabia.探索综合方法:沙特阿拉伯乳腺癌幸存者补充医学实践的见解
Cureus. 2024 Jan 15;16(1):e52282. doi: 10.7759/cureus.52282. eCollection 2024 Jan.
5
Lay etiology concepts of cancer patients do not correlate with their usage of complementary and/or alternative medicine.癌症患者的非医学病因观念与其补充和/或替代医学的使用无关。
J Cancer Res Clin Oncol. 2023 Aug;149(9):6067-6074. doi: 10.1007/s00432-022-04528-7. Epub 2023 Jan 18.
6
Rare Diseases: Needs and Impact for Patients and Families: A Cross-Sectional Study in the Valencian Region, Spain.罕见病:患者及其家庭的需求和影响:西班牙巴伦西亚地区的一项横断面研究。
Int J Environ Res Public Health. 2022 Aug 19;19(16):10366. doi: 10.3390/ijerph191610366.
7
Effectiveness of Fucoidan on Supplemental Therapy in Cancer Patients: A Systematic Review.岩藻依聚糖对癌症患者辅助治疗的有效性:一项系统评价
Healthcare (Basel). 2022 May 17;10(5):923. doi: 10.3390/healthcare10050923.
8
Pharmacogenomics of in vitro response of the NCI-60 cancer cell line panel to Indian natural products.NCI-60 癌细胞系panel 对印度天然产物体外反应的药物基因组学研究。
BMC Cancer. 2022 May 7;22(1):512. doi: 10.1186/s12885-022-09580-7.
9
Self-efficacy in relation to the use of complementary and alternative medicine, lifestyle choices and cancer aetiology.自我效能与补充和替代医学的使用、生活方式选择和癌症病因的关系。
J Cancer Res Clin Oncol. 2022 Oct;148(10):2707-2715. doi: 10.1007/s00432-021-03857-3. Epub 2021 Nov 23.
10
Complementary Medicine in the Treatment of Cancer Patients.补充医学在癌症患者治疗中的应用。
Dtsch Arztebl Int. 2021 Oct 1;118(39):654-659. doi: 10.3238/arztebl.m2021.0277.
有多少癌症患者使用补充和替代医学:系统评价和荟萃分析。
Integr Cancer Ther. 2012 Sep;11(3):187-203. doi: 10.1177/1534735411423920. Epub 2011 Oct 21.
4
Complementary and alternative medicine and supportive care at leading cancer centers: a systematic analysis of websites.主流癌症中心的补充和替代医学与支持性护理:网站的系统分析。
J Altern Complement Med. 2010 Feb;16(2):183-6. doi: 10.1089/acm.2009.0354.
5
The role of the Internet in cancer patients' engagement with complementary and alternative treatments.互联网在癌症患者参与补充和替代疗法中的作用。
Health (London). 2008 Apr;12(2):139-55. doi: 10.1177/1363459307086841.
6
Lesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies.女性特定癌症患者与其他人群使用补充替代医学(CAM)的比较所带来的启示:是时候关注CAM疗法的相互作用风险了。
Integr Cancer Ther. 2007 Dec;6(4):313-44. doi: 10.1177/1534735407309257.
7
Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.参加I期试验的晚期癌症患者的补充和替代医学:一项关于预后、生活质量及决策偏好的研究。
J Clin Oncol. 2007 Feb 10;25(5):548-54. doi: 10.1200/JCO.2005.03.9800.
8
Prevalence of complementary and alternative medicine use in cancer patients during treatment.癌症患者在治疗期间使用补充和替代医学的患病率。
Support Care Cancer. 2005 Oct;13(10):806-11. doi: 10.1007/s00520-004-0770-7. Epub 2005 Feb 15.
9
Use of complementary and alternative medicine in cancer patients: a European survey.癌症患者使用补充和替代医学:一项欧洲调查。
Ann Oncol. 2005 Apr;16(4):655-63. doi: 10.1093/annonc/mdi110. Epub 2005 Feb 2.
10
A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.一项针对近期诊断为前列腺癌的男性使用补充和替代医学情况的基于人群的调查。
Integr Cancer Ther. 2003 Sep;2(3):212-6. doi: 10.1177/1534735403256207.